Payden Equity Income Fund Adviser Cl (PYVAX) Forecast
See the Price Targets and Ratings of:
PYVAX Analyst Rating
Moderate Buy
72ConsensusRatings
64Buy8Hold0Sell
Based on the Wall Street analyst consensus for 72 of PYVAX’s holdings.
PYVAX Analyst Price Target
Average Price Target
$22.02▲(15.27% Upside)
Based on Wall Street analyst 12-month price targets for 72 of Payden Equity Income Fund Adviser Cl’s holdings in the last 3 months. The average price target is $22.02 with a high forecast of $25.42 and a low forecast of $18.28. The average price target represents a 15.27% change from the last price of $19.10.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$25.42
Average$22.02
Low$18.28
Past 12 Months12 Month Forecast$15$17.75$20.5$23.3$26Feb2026May2026Aug2026Nov2026Nov2027
What is PYVAX’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 72 of PYVAX’s holdings, Payden Equity Income Fund Adviser Cl’s 12-month average price target is $22.02.
What is PYVAX’s upside potential, based on the analysts’ average price target?
PYVAX’s average price target of $22.02 represents a 15.27% upside from its last price of $19.10.
Is PYVAX a Buy, Sell or Hold?
Payden Equity Income Fund Adviser Cl has a consensus rating of Moderate Buy, based on the analyst consensus for 72 of PYVAX’s holdings: 64 rated Buy, 8 rated Hold and 0 rated Sell.
What is Payden Equity Income Fund Adviser Cl’s price target?
The average price target for Payden Equity Income Fund Adviser Cl is $22.02, based on Wall Street analyst 12-month price targets for 72 of PYVAX’s holdings, issued in the past 3 months. The highest price target is $25.42 and the lowest is $18.28. The average price target represents a 15.27% increase from the last price of $19.10.
How can I buy shares of PYVAX?
You can buy shares of PYVAX through a brokerage account. Compare brokers on our Best Online Brokers page.